Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Entera Bio Beat Earnings?

Entera Bio (ENTX) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Entera Bio’s job postings, web traffic, and employee business outlook. See the full ENTX stock analysis or the earnings calendar for upcoming reports.

Entera Bio Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue42,00082,00042,000—————
Gross margin0.0%0.0%0.0%—————
Operating margin-7,192.9%-2,850.0%-6,102.4%—————
Net income-3M-2.4M-2.6M-2.7M-3.2M-3M-3.5M-7.3M
Net margin-7,192.9%-2,875.6%-6,111.9%—————
EPS————————

Entera Bio Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Entera Bio’s quarterly revenue moved from $42,000 to $0.

When Is Entera Bio’s Next Earnings Date?

Entera Bio reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the ENTX earnings calendar.

Frequently Asked Questions: Entera Bio Earnings

Entera Bio's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Entera Bio reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ENTX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.